Korean Ministry of Culture

Let’s MZ, International Youth Exchange Program, Successfully Completed

Retrieved on: 
Jeudi, novembre 24, 2022
Technology, Environmental Issues, Advertising, Communications, Other Energy, Millennials, Audio, Video, Generation Z, Environment, Energy, Consumer, Sustainable Development Goals, Multimedia, Family, Student, First Nations in Ontario, Gender equality, UN, Korean Ministry of Culture, United Nations, Tourism

Lets MZ, an international youth exchange program organized by Boramae Youth Center and hosted by the South Korean Ministry of Gender Equality and Family and Korea Youth Work Agency , was successfully completed.

Key Points: 
  • Lets MZ, an international youth exchange program organized by Boramae Youth Center and hosted by the South Korean Ministry of Gender Equality and Family and Korea Youth Work Agency , was successfully completed.
  • The videos depicted differences in applications of the three SDGs in each country as viewed by youths of Korea and overseas students studying in Korea.
  • I hope the advertising video about the UN SDGs, the issues of the international society, will help youths of Korea and around the world to grow as global leaders who exercise positive influence.
  • For details about the program, please call Boramae Youth Center (+82-02-834-7233,4), or visit official website and Facebook .

GC LabTech Launches Partnership with 1health.io to Deploy Innovative Lab Tests Direct-to-Consumer

Retrieved on: 
Lundi, octobre 24, 2022
Health, Technology, Infectious Diseases, Other Science, Software, Science, CAP, ISO, Blood, CLIA, Efficiency, Public health, List of pathologists, Laboratory, E-commerce, California Department, CAGR, Korean Ministry of Culture, GC, Research, College of American Pathologists, South Dakota State Test of Educational Progress, Partnership, Technology, International Organization (journal), Transparency (market), Starbucks, Health, Association, United, Plasma, FDA, Medical device, Fine chemical, Food

GC LabTech, a subsidiary of GC Biopharma of South Korea, and a CAP & ISO accredited, FDA-registered specialty laboratory with life-saving plasma tests, selects 1health.io, an industry-leading software company revolutionizing the way laboratories expand testing into the at-home markets, to deliver its innovative new lab tests direct-to-consumers.

Key Points: 
  • GC LabTech, a subsidiary of GC Biopharma of South Korea, and a CAP & ISO accredited, FDA-registered specialty laboratory with life-saving plasma tests, selects 1health.io, an industry-leading software company revolutionizing the way laboratories expand testing into the at-home markets, to deliver its innovative new lab tests direct-to-consumers.
  • The new partnership between 1health and GC LabTech enables GC LabTech to sell its innovative new health and wellness tests into the $1 billion direct-to-consumer lab testing market, which is forecasted to grow to $8.8 billion by 2031 according to research group Transparency Marketing in its report North America Direct-to-Consumer Laboratory Testing Market Insights, 2021-2031 published in Q1 2022.
  • Known for its highly accurate, optimized efficiency, and fast turnaround service, GC LabTech is applying its high-performance lab testing capabilities to the direct-to-consumer segment.
  • Previously, GC Lab Tech had explored the direct-to-consumer market but found it did not have the front-end or back-end infrastructure to launch the tests to the consumer.

RZNOMICS Inc. received FDA approval to initiate clinical development of trans-splicing ribozyme-based RNA editing technology in liver cancer patients

Retrieved on: 
Mardi, octobre 25, 2022
RNA transfection, Therapy, Achievement, IND, Korean Ministry of Culture, U.S. FDA, Patient, Hepatocellular carcinoma, RNA, HCC, Technology, Cancer, Mutation, Retinitis, Alzheimer's disease, CEO, Safety, Toxic Small RNA, Clinical trial, Mall of America, DNA, Glioblastoma, FDA, Retinitis pigmentosa, Reverse transcriptase, Duke University, Pharmaceutical industry, Vaccine, Food

Therefore, U.S. FDA approval allows Rznomics to start an international clinical study in HCC patients treating them with RZ-001 and therapeutic RNA editing.

Key Points: 
  • Therefore, U.S. FDA approval allows Rznomics to start an international clinical study in HCC patients treating them with RZ-001 and therapeutic RNA editing.
  • Ribozyme-based RNA editing technology developed by Rznomics has unique features, differentiating it from other nucleic acid-based editing approaches, as follows: (1) A single RNA molecule is capable of both suppressing target RNA expression and simultaneously expressing a therapeutic RNA.
  • Through the advanced development phase, I hope Rznomics can provide more new therapeutic options to patients suffering from intractable diseases.
  • Also under development are ribozyme-based RNA editing treatments for Alzheimer's disease (RZ-003) and inherited retinal dystrophies, called Retinitis pigmentosa (RZ-004).

RZNOMICS Inc. received FDA approval to initiate clinical development of trans-splicing ribozyme-based RNA editing technology in liver cancer patients

Retrieved on: 
Mardi, octobre 25, 2022
RNA transfection, Therapy, Achievement, IND, Korean Ministry of Culture, U.S. FDA, Patient, Hepatocellular carcinoma, RNA, HCC, Technology, Cancer, Mutation, Retinitis, Alzheimer's disease, CEO, Safety, Toxic Small RNA, Clinical trial, Mall of America, DNA, Glioblastoma, FDA, Retinitis pigmentosa, Reverse transcriptase, Duke University, Pharmaceutical industry, Vaccine, Food

Therefore, U.S. FDA approval allows Rznomics to start an international clinical study in HCC patients treating them with RZ-001 and therapeutic RNA editing.

Key Points: 
  • Therefore, U.S. FDA approval allows Rznomics to start an international clinical study in HCC patients treating them with RZ-001 and therapeutic RNA editing.
  • Ribozyme-based RNA editing technology developed by Rznomics has unique features, differentiating it from other nucleic acid-based editing approaches, as follows: (1) A single RNA molecule is capable of both suppressing target RNA expression and simultaneously expressing a therapeutic RNA.
  • Through the advanced development phase, I hope Rznomics can provide more new therapeutic options to patients suffering from intractable diseases.
  • Also under development are ribozyme-based RNA editing treatments for Alzheimer's disease (RZ-003) and inherited retinal dystrophies, called Retinitis pigmentosa (RZ-004).

Bertis Establishes U.S. Operations to Bring Novel Proteomics-Based Diagnostics to the U.S. Market

Retrieved on: 
Mardi, octobre 11, 2022
Proteomics, LinkedIn, Pancreatic cancer, CLIA, Medicine, Korean Intellectual Property Office, Diagnosis, Machine learning, Korean Ministry of Culture, Patient, Hospital, American Chemical Society, Raffles Medical Group, Research, Disorder, Cancer, Multimedia, Artificial intelligence, Precision medicine, Technology, Cancer Breakthroughs 2020, PASS, Solution, Human body, Biomarker, Raffles, National Cancer Institute, AI, Breast cancer, PMID, American, Ministry of Food and Drug Safety, Protein, Journal, Proteome, Plasma, Ministry, NET, Ovarian cancer, Journal of Proteome Research, View, Pharmaceutical industry, Medical device, Medical imaging, Dentistry, Bertie the Brain, Food

SEOUL, Korea, Oct. 11, 2022 /PRNewswire/ -- Bertis Inc., a South Korean proteomics-based precision medicine technology company, announced today it has established a U.S.-based wholly-owned entity to expand the company's global presence and primarily provide access to the growing U.S. clinical testing market.

Key Points: 
  • The company has successfully commercialized in South Korea MASTOCHECKTM, the world's first proteomics-based breast cancer blood test solution.
  • Bertis has gained a foothold in the Asian market by recently signing a contract with one of Singapore's largest medical groups, Raffles Medical Group, to supply MASTOCHECKTM.
  • Recently, Bertis' research team presented protein biomarkers for early diagnosis of high-grade serous ovarian cancer (HGSOC) with 95% accuracy4.
  • Bertis' capabilities range from cancer, disorder biomarker discovery, low-cost diagnostics manufacturing and analysis services.

KRTL INTERNATIONAL AND ICANN VENTURES TO LAUNCH CANNABIS EDUCATION PROGRAM IN KOREA

Retrieved on: 
Vendredi, septembre 23, 2022
Diamond, Knowledge, Health, Faculty, Cannabinoid, Department, Academy, Student, Ministry, Yeungnam University, Legislation, Creativity, Company, Growth, SHI International Corp, Partnership, Industry, Korean Ministry of Culture, Program, Patient, Genetics, History, Curriculum, OTC, CEO, Private sector, Ministry of Food and Drug Safety, Pathology, Method, South Korea, REAL, Marketing, Education, Tutoring, Agriculture, Food, CBD, Cannabis, Horticulture, Hemp

KRTL International Corp., a subsidiary of KRTL Holding Group, Inc. (OTC: KRTL) and ICANN Ventures have signed multiple strategic agreements to be executed accordingly.

Key Points: 
  • KRTL International Corp., a subsidiary of KRTL Holding Group, Inc. (OTC: KRTL) and ICANN Ventures have signed multiple strategic agreements to be executed accordingly.
  • Yeungnam University, Department of Horticulture & Life Science, is a leading provider of education in Korea.
  • Kai Kim, the CEO of KRTL International Corp: Education is fundamental to the development and growth of all sustainable infrastructure.
  • The Company operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp., with precision and excellence and continues to create and strengthen the KRTL reputation.

AI Data Company INFINIQ Launches Data Anonymization Solution 'Wellid' Revealed at Autonomous Vehicle Expo 2022 in San Jose

Retrieved on: 
Vendredi, septembre 9, 2022
Technology, Automotive, Security, Automotive Manufacturing, Manufacturing, Software, Autonomous Driving, Vehicles, Data Management, Artificial Intelligence, Nvidia, CEO, Time, Korean Ministry of Culture, OEM, Government, API, So I Married the Anti-fan, Multimedia, Inception, Deepfake, DataOps, Data collection, Data, 2600-series (CTA), AI, Data anonymization, Satellite navigation device, Science

INFINIQ , the leading AI data company in South Korea, has introduced a data anonymization solution that automatically detects and anonymizes all identifiable faces and license plates in videos and images captured.

Key Points: 
  • INFINIQ , the leading AI data company in South Korea, has introduced a data anonymization solution that automatically detects and anonymizes all identifiable faces and license plates in videos and images captured.
  • View the full release here: https://www.businesswire.com/news/home/20220909005009/en/
    INFINIQ is introducing its data anonymization solution to visitors at Autonomous Vehicle Expo 2022 in San Jose.
  • Wellid was showcased at the Autonomous Vehicle Expo 2022 in San Jose which was held from 7~9th September.
  • It provides data collection, anonymization, and annotation services in all domains including autonomous driving, retail, security, smart city, robot, and healthcare.

4DREPLAY Wins IR Pitching Competition at M360

Retrieved on: 
Lundi, août 22, 2022
Ministry, Technology, VAR, ICT, Integrated Global System Model, Solution, Korean Ministry of Culture, Sport, Ministry of Science and ICT, Fourth Industrial Revolution, Multimedia, IR, Trailblazer, Silicon, GSMA, Mobile, Ecosystem, Video game, Entertainment, Science

SEOUL, South Korea, Aug. 22, 2022 /PRNewswire/ -- 4DREPLAY , a four-dimensional video technology startup and member of the Born2Global Centre , announced that it won the investor relations (IR) pitch competition at Mobile 360 Asia Pacific 2022 (M360 2022), which was held at JW Marriott South Beach in Singapore.

Key Points: 
  • SEOUL, South Korea, Aug. 22, 2022 /PRNewswire/ -- 4DREPLAY , a four-dimensional video technology startup and member of the Born2Global Centre , announced that it won the investor relations (IR) pitch competition at Mobile 360 Asia Pacific 2022 (M360 2022), which was held at JW Marriott South Beach in Singapore.
  • The IR pitch competition was held in an audition format with six expert judges and online and offline audience polling.A total of eight Korean startups, including 4DREPLAY, and four overseas startups participated in this fierce competition.
  • 4DREPLAY managed to win the competition, drawing enthusiastic applause from both the judges and audience.
  • 4DREPLAY CEO Jung Hongsu commented, "We were able to present our own technology and finish as the finalist in this IR pitch competition."

Busan IT Industry Promotion Agency Selects 2022 Korea-ASEAN XR Joint Project as Bridgehead to Enter ASEAN Market

Retrieved on: 
Mardi, août 16, 2022
Electronic Games, Mobile, Wireless, Technology, Communications, Entertainment, Metaverse, Retail, Tourist Attractions, General Entertainment, Vacation, Other Travel, Social Media, Travel, Web3, Audio, Video, Other Technology, Telecommunications, Software, Other Entertainment, Internet, Online, Hardware, Other Retail, Consumer Electronics, Safety, Exhibition, CEO, UNESCO, National IT Industry Promotion Agency, Telehealth, NIPA, Korean Ministry of Culture, ASEAN, ROK, Bangkok National Museum, World of McIntosh Experience Center, World Heritage Site, Imperial City, YST, XR, BIPA, ICT, National, VR, AR, ASEAN–Republic of Korea Commemorative Summit, Renewable energy, Science, Metaverse

Busan IT Industry Promotion Agency (President & CEO Mun-Seob Jeong), through the ASEAN-ROK ICT Convergence Village, announced the selection of nine new projects for the 2022 Korea-ASEAN XR Joint Project to demonstrate and to establish competitive Korean XR companies, and to expand advanced XR and Metaverse technology into the ASEAN market.

Key Points: 
  • Busan IT Industry Promotion Agency (President & CEO Mun-Seob Jeong), through the ASEAN-ROK ICT Convergence Village, announced the selection of nine new projects for the 2022 Korea-ASEAN XR Joint Project to demonstrate and to establish competitive Korean XR companies, and to expand advanced XR and Metaverse technology into the ASEAN market.
  • The project with its purpose of expanding ICT exchange and mutual growth in Korea and ASEAN is under the National IT Industry Promotion Agency (NIPA) and Busan IT Industry Promotion Agency (BIPA), hosted by the Korean Ministry of Science and ICT , and Busan Metropolitan City .
  • XR Convergence Sports Contents and Experience Center Demonstration Project in Myanmar (Insol M&T Co., Ltd., KMPI Consortium Co., Ltd.)
    5.
  • Mun-Seob Jeong, President & CEO of BIPA, said, I hope that the 2022 Korea-ASEAN XR Joint Project becomes a good opportunity for ASEAN and ROK to start collaborating on various projects.

Busan IT Industry Promotion Agency Hosts 2022 Global Metaverse Conference & ASEAN-ROK Forum

Retrieved on: 
Mercredi, août 10, 2022
Internet, Metaverse, Technology, Artificial Intelligence, Software, Metropolis, Industry, CEO, National IT Industry Promotion Agency, NIPA, NVIDIA, Korean Ministry of Culture, ASEAN, NFT, BEXCO, AMD, XR, South Korea, BIPA, ICT, National, Conference, VR, AR, Pharmaceutical industry, Science, Pinscreen animation, Metaverse, Oculus

Busan Metropolitan City (Mayor Heong-Joon Park) and Busan IT Industry Promotion Agency (President & CEO Mun-Seob Jeong) announced that the 2022 Global Metaverse Conference & ASEAN-ROK Forum will be held for Korean and international Metaverse businesses and Busan citizens at BEXCO from August 18 to 19.

Key Points: 
  • Busan Metropolitan City (Mayor Heong-Joon Park) and Busan IT Industry Promotion Agency (President & CEO Mun-Seob Jeong) announced that the 2022 Global Metaverse Conference & ASEAN-ROK Forum will be held for Korean and international Metaverse businesses and Busan citizens at BEXCO from August 18 to 19.
  • The event will be hosted by the Korean Ministry of Science and ICT and Busan Metropolitan City and organized by the National IT Industry Promotion Agency (NIPA), and Busan IT Industry Promotion Agency (BIPA) to stimulate Metaverse business collaborations and exchange in the ASEAN-ROK (Republic of Korea) regions.
  • The Global Metaverse Conference will include lectures and discussions on Metaverse, NFT, and key industry trends as well as ways to collaborate with ASEAN under the theme of Metaverse, the beginning of a New World.
  • The conference will provide lectures with different perspectives of experts covering state-of-the-art Metaverse technology trends and its service application field, industry trend analysis, global and Korean market analysis, and the vision and challenge of the Metaverse.